Your browser doesn't support javascript.
loading
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
Rustad, Even H; Misund, Kristine; Bernard, Elsa; Coward, Eivind; Yellapantula, Venkata D; Hultcrantz, Malin; Ho, Caleb; Kazandjian, Dickran; Korde, Neha; Mailankody, Sham; Keats, Jonathan J; Akhlaghi, Theresia; Viny, Aaron D; Mayman, David J; Carroll, Kaitlin; Patel, Minal; Famulare, Christopher A; Op Bruinink, Davine Hofste; Hutt, Kasey; Jacobsen, Austin; Huang, Ying; Miller, Jeffrey E; Maura, Francesco; Papaemmanuil, Elli; Waage, Anders; Arcila, Maria E; Landgren, Ola.
Afiliação
  • Rustad EH; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Misund K; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Bernard E; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Coward E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yellapantula VD; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Hultcrantz M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ho C; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kazandjian D; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Korde N; Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Mailankody S; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Keats JJ; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Akhlaghi T; Translational Genomics Research Institute (TGen), Phoenix, Arizona.
  • Viny AD; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mayman DJ; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Carroll K; Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Patel M; Adult Reconstruction and Joint Replacement Division, Hospital for Special Surgery, New York, New York.
  • Famulare CA; Adult Reconstruction and Joint Replacement Division, Hospital for Special Surgery, New York, New York.
  • Op Bruinink DH; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hutt K; Center for Hematological Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Jacobsen A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Huang Y; Invivoscribe, Inc, San Diego, California.
  • Miller JE; Invivoscribe, Inc, San Diego, California.
  • Maura F; Invivoscribe, Inc, San Diego, California.
  • Papaemmanuil E; Invivoscribe, Inc, San Diego, California.
  • Waage A; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Arcila ME; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Landgren O; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Am J Hematol ; 94(12): 1364-1373, 2019 12.
Article em En | MEDLINE | ID: mdl-31571261
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico de Cadeia Pesada de Linfócito B / Rearranjo Gênico de Cadeia Leve de Linfócito B / Regiões Determinantes de Complementaridade / Sequenciamento de Nucleotídeos em Larga Escala / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico de Cadeia Pesada de Linfócito B / Rearranjo Gênico de Cadeia Leve de Linfócito B / Regiões Determinantes de Complementaridade / Sequenciamento de Nucleotídeos em Larga Escala / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2019 Tipo de documento: Article